Product Information
PREVALITE PACKET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.8327 per EA under NDC 00245003642. Its NADAC has been published 667 times since Nov 28, 2013.
FDA first approved this application on Feb 22, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 g/5.5g
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245003642
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA073263FDA Approved
2/22/1996
TE Code
AB
On Market Since
2/1/1996
Pharmacological Classes
Price Statistics
The NADAC for PREVALITE PACKET has been published 667 times since Nov 28, 2013, and over the history we have for it it has declined 52.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8327 per EA |
|---|---|
| All-time high | $2.1232 (Jul 15, 2015) |
| All-time low | $0.7336 (Apr 17, 2024) |
| 52-week high | $0.9002 |
| 52-week low | $0.7955 |
| Median price | $1.4043 |
| Average price | $1.4432 |
| Largest weekly change | +21.4% (Jun 19, 2024) |
| Weeks tracked | 667 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
cholestyramine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid Sequestrant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREVALITE PACKET?
The current National Average Drug Acquisition Cost (NADAC) for PREVALITE PACKET, manufactured by Upsher-Smith Laboratories LLC, is $0.8327 per EA (NDC 00245003642), effective Sep 30, 2026.
How has the price of PREVALITE PACKET changed over time?
Over the history we have for it, the NADAC for PREVALITE PACKET has declined 52.9%. It has been tracked across 667 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PREVALITE PACKET?
Since Nov 28, 2013, the NADAC for PREVALITE PACKET has ranged from a low of $0.7336 (Apr 17, 2024) to a high of $2.1232 (Jul 15, 2015), with a median of $1.4043 per EA.
Are there cheaper alternatives to PREVALITE PACKET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PREVALITE PACKET in a comparable dosage form, but none are currently priced below it.
Who manufactures PREVALITE PACKET?
PREVALITE PACKET (NDC 00245003642) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.